Could Kanabo be the best share to buy for me for the long-term?

The Kanabo share price has fallen to less than half its post-listing highs. But can the company’s recent progress reverse this trend?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Consider this. Cannabis regulations are being relaxed. This could mean a spurt in legal demand. Companies in the segment can, of course, benefit from this. One of these is the medical cannabis producer Kanabo (LSE: KNB).

The company’s unique selling point is a metered dosage inhalation device, that allows prescription of exact quantities to be consumed for health challenges like pain management. This is a clean alternative to smoking it. 

Kanabo makes progress

Kanabo is now ready to ship cartridges required to use the device to the UK under the brand name NOIDECS. These have been manufactured in Poland in partnership with PharmaCann Polska, which I talked about when I last wrote of the stock.

This is fairly quick progress. In the last four months, the company has gone from signing partnerships for both production and distribution of its products, to actually getting them in the market. 

Awaiting performance updates

As a potential investor, I am now keen to know how the market responds to it. The numbers available for the company, albeit based on its pilots, are somewhat encouraging. I will now look out for its next operational as well as financial update to see how its market is growing. 

If these updates are positive, they could well give a fillip to the Kanabo share price, which has languished for some time now. Even though its initial public offering (IPO) at the London Stock Exchange a few months ago was encouraging, the share has fallen quite a bit since. It is now trading at less than half the highs of around 41p it saw shortly after listing. 

Pros and cons for the Kanabo share

I can see why. The company operates in a still nascent sector that is vulnerable to regulatory changes. Its product’s value is still unproven and it is just about getting into the market. And even if the sector does take off, individual companies can still struggle from a host of issues from effective management to market penetration. 

At the same time, many of the big and successful companies we see today were fledgling startups in new market segments at some point. If cannabis does take off in a big way, then there is potential for Kanabo to become the best share to buy in a decade. 

Best share to buy?

However, it is too early to say what will happen next. I would like to see more updates from Kanabo first. This will help me to assess its own pace of progress as outlined in its latest release. But crucially, as I was saying earlier, it will help me understand how the market responds to its products. 

The past year has been a challenging one for it, like it has been for many others during the pandemic. But even since its listing in February, I do not have any new numbers to work with. Once they do, I will be in a better position to determine if Kanabo can indeed be a great investment. Until then, I will watch the stock.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »